|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 330.91 USD | -0.77% |
|
+0.35% | -34.58% |
| 03/12 | Wolfe Research Adjusts PT on UnitedHealth Group to $375 From $330, Maintains Outperform Rating | MT |
| 02/12 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
Company Valuation: UnitedHealth Group Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 3,32,732 | 4,72,941 | 4,95,373 | 4,86,945 | 4,65,535 | 2,99,751 | - | - |
| Change | - | 42.14% | 4.74% | -1.7% | -4.4% | -35.61% | - | - |
| Enterprise Value (EV) 1 | 3,59,278 | 4,95,037 | 5,14,300 | 5,19,854 | 5,13,326 | 3,54,354 | 3,52,407 | 3,52,930 |
| Change | - | 37.79% | 3.89% | 1.08% | -1.26% | -30.97% | -0.55% | 0.15% |
| P/E ratio | 21.9x | 27.8x | 25x | 22.1x | 32.6x | 22.1x | 20.2x | 17.2x |
| PBR | 5.1x | 6.28x | 6.18x | 5.48x | 5x | 3.03x | 2.87x | 2.74x |
| PEG | - | 2.2x | 1.5x | 1.7x | -0.9x | -6.24x | 2.15x | 1x |
| Capitalization / Revenue | 1.29x | 1.64x | 1.53x | 1.31x | 1.16x | 0.67x | 0.66x | 0.63x |
| EV / Revenue | 1.4x | 1.72x | 1.59x | 1.4x | 1.28x | 0.79x | 0.77x | 0.74x |
| EV / EBITDA | 14.2x | 18.3x | 16.2x | 14.3x | 14.1x | 13.5x | 12.4x | 11.2x |
| EV / EBIT | 16x | 20.7x | 18.1x | 16.1x | 15.9x | 16.2x | 14.6x | 13.2x |
| EV / FCF | 17.9x | 24.9x | 22x | 20.2x | 24.8x | 17.8x | 19.4x | 16.6x |
| FCF Yield | 5.6% | 4.02% | 4.55% | 4.94% | 4.03% | 5.6% | 5.16% | 6.02% |
| Dividend per Share 2 | 4.83 | 5.6 | 6.4 | 7.29 | 8.18 | 8.747 | 9.082 | 9.235 |
| Rate of return | 1.38% | 1.12% | 1.21% | 1.38% | 1.62% | 2.64% | 2.74% | 2.79% |
| EPS 2 | 16.03 | 18.08 | 21.18 | 23.86 | 15.51 | 14.96 | 16.37 | 19.28 |
| Distribution rate | 30.1% | 31% | 30.2% | 30.6% | 52.7% | 58.5% | 55.5% | 47.9% |
| Net sales 1 | 2,57,141 | 2,87,597 | 3,24,162 | 3,71,622 | 4,00,278 | 4,47,523 | 4,57,237 | 4,78,079 |
| EBITDA 1 | 25,296 | 27,073 | 31,835 | 36,330 | 36,386 | 26,183 | 28,313 | 31,644 |
| EBIT 1 | 22,405 | 23,970 | 28,435 | 32,358 | 32,287 | 21,883 | 24,057 | 26,832 |
| Net income 1 | 15,403 | 17,285 | 20,120 | 22,381 | 14,405 | 13,632 | 14,836 | 17,439 |
| Net Debt 1 | 26,546 | 22,096 | 18,927 | 32,909 | 47,791 | 54,603 | 52,656 | 53,179 |
| Reference price 2 | 350.68 | 502.14 | 530.18 | 526.47 | 505.86 | 330.91 | 330.91 | 330.91 |
| Nbr of stocks (in thousands) | 9,48,821 | 9,41,851 | 9,34,349 | 9,24,925 | 9,20,284 | 9,05,839 | - | - |
| Announcement Date | 20/01/21 | 19/01/22 | 13/01/23 | 12/01/24 | 16/01/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 22.12x | 0.79x | 13.53x | 2.64% | 30TCr | |
| 13.07x | 0.49x | 8.75x | 2.02% | 7.35TCr | |
| 11.02x | 0.35x | 7.36x | 2.21% | 7.09TCr | |
| 20.49x | 0.3x | 9.43x | 1.42% | 3.1TCr | |
| -3.79x | 0.11x | 22.09x | -.--% | 1.88TCr | |
| 12.82x | 0.16x | 5.7x | -.--% | 780.56Cr | |
| -180.65x | 0.93x | 38.06x | -.--% | 391.18Cr | |
| 36.53x | 1.52x | 8.87x | -.--% | 207.08Cr | |
| -14.92x | 0.62x | 59.3x | -.--% | 133.3Cr | |
| 40.06x | 3.52x | 17.48x | 0.46% | 39Cr | |
| Average | -4.33x | 0.88x | 19.06x | 0.87% | 5.1TCr | |
| Weighted average by Cap. | 16.49x | 0.63x | 12.22x | 2.24% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- UNH Stock
- Valuation UnitedHealth Group Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition